Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
03 09 2021
Historique:
pubmed: 22 7 2021
medline: 18 9 2021
entrez: 21 7 2021
Statut: ppublish

Résumé

SARS-CoV-2 has had a disproportionate impact on nonhospital health care settings, such as long-term-care facilities (LTCFs). The communal nature of these facilities, paired with the high-risk profile of residents, has resulted in thousands of infections and deaths and a high case fatality rate. To detect presymptomatic infections and identify infected workers, we performed weekly surveillance testing of staff at two LTCFs, which revealed a large outbreak at one of the sites. We collected serum from staff members throughout the study and evaluated it for binding and neutralization to measure seroprevalence, seroconversion, and type and functionality of antibodies. At the site with very few incident infections, we detected that over 40% of the staff had preexisting SARS-CoV-2 neutralizing antibodies, suggesting prior exposure. At the outbreak site, we saw rapid seroconversion following infection. Neutralizing antibody levels were stable for many weeks following infection, suggesting a durable, long-lived response. Receptor-binding domain antibodies and neutralizing antibodies were strongly correlated. The site with high seroprevalence among staff had two unique introductions of SARS-CoV-2 into the facility through seronegative infected staff during the period of study, but these did not result in workplace spread or outbreaks. Together, our results suggest that a high seroprevalence rate among staff can contribute to immunity within a workplace and protect against subsequent infection and spread within a facility.

Identifiants

pubmed: 34287058
doi: 10.1128/Spectrum.00224-21
pmc: PMC8552744
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
RNA, Viral 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0022421

Subventions

Organisme : NIAID NIH HHS
ID : F32 AI150123
Pays : United States
Organisme : Colorado State University (CSU)
Organisme : Boettcher Foundation (The Boettcher Foundation)

Références

JAMA Netw Open. 2021 Mar 1;4(3):e214302
pubmed: 33749770
Cell Rep Med. 2020 Jun 23;1(3):100040
pubmed: 32835303
Telemed J E Health. 2021 Jan;27(1):102-106
pubmed: 32644899
BMC Med. 2020 Dec 8;18(1):386
pubmed: 33287821
J Am Med Dir Assoc. 2021 Feb;22(2):256-257
pubmed: 33358724
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Nat Rev Immunol. 2021 Apr;21(4):245-256
pubmed: 33723416
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Euro Surveill. 2020 Jun;25(22):
pubmed: 32524949
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859
pubmed: 33301429
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
Infect Control Hosp Epidemiol. 2021 Oct;42(10):1173-1180
pubmed: 33308357
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
Clin Microbiol Infect. 2004 Dec;10(12):1062-6
pubmed: 15606632
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Nat Rev Immunol. 2020 Oct;20(10):593
pubmed: 32873886
Science. 2020 Aug 7;369(6504):650-655
pubmed: 32571838
Clin Infect Dis. 2021 Sep 7;73(5):e1208-e1211
pubmed: 33270134
Clin Infect Dis. 2021 Nov 2;73(9):e3095-e3097
pubmed: 32927483
Cell Tissue Bank. 2021 Sep;22(3):511-518
pubmed: 33523333
Emerg Microbes Infect. 2021 Dec;10(1):905-912
pubmed: 33870851
Immunity. 2020 Nov 17;53(5):925-933.e4
pubmed: 33129373
J Am Med Dir Assoc. 2021 Jun;22(6):1133-1137
pubmed: 33861978
Trends Immunol. 2020 May;41(5):355-359
pubmed: 32249063
Cell. 2021 Jan 7;184(1):169-183.e17
pubmed: 33296701
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115294
pubmed: 33387896
J Am Geriatr Soc. 2020 Oct;68(10):2153-2162
pubmed: 32735036
Am J Infect Control. 2015 Feb;43(2):100-6
pubmed: 25637113
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Int J Hyg Environ Health. 2020 Sep;230:113599
pubmed: 32823069
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
JCI Insight. 2020 Oct 2;5(19):
pubmed: 32870820
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
Emerg Infect Dis. 2020 Oct;26(10):2416-2419
pubmed: 32614768
J Microbiol Immunol Infect. 2020 Jun;53(3):444-446
pubmed: 32303483
Emerg Microbes Infect. 2021 Dec;10(1):774-781
pubmed: 33830901
PLoS One. 2021 Feb 12;16(2):e0246864
pubmed: 33577615
Am J Infect Control. 2021 Apr;49(4):438-446
pubmed: 33022331
Clin Infect Dis. 2021 Feb 16;72(4):686-689
pubmed: 32667967
Emerg Infect Dis. 2021 Apr;27(4):1229-1231
pubmed: 33755002
N Engl J Med. 2020 Oct 8;383(15):1483-1488
pubmed: 32706956
Int J Environ Res Public Health. 2019 Jun 05;16(11):
pubmed: 31195661
J Immunol. 2021 Jan 1;206(1):109-117
pubmed: 33208457
Pathogens. 2021 Jan 30;10(2):
pubmed: 33573221
Clin Infect Dis. 2021 Sep 15;73(6):e1365-e1367
pubmed: 33768222
Front Med (Lausanne). 2021 Mar 12;8:636160
pubmed: 33777979
Signal Transduct Target Ther. 2020 Sep 2;5(1):180
pubmed: 32879307
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 32958614
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Eur J Clin Invest. 2021 Jul;51(7):e13573
pubmed: 33870493
J Clin Invest. 2020 Nov 2;130(11):6141-6150
pubmed: 32764200
Am J Kidney Dis. 2020 Oct;76(4):490-499.e1
pubmed: 32628990
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033173
Microbiol Spectr. 2021 Dec 22;9(3):e0100321
pubmed: 34756092
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Microorganisms. 2021 Feb 25;9(3):
pubmed: 33669151
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):273-277
pubmed: 33630817
Syst Rev. 2020 Sep 25;9(1):218
pubmed: 32977848
Clin Diagn Lab Immunol. 2005 Nov;12(11):1317-21
pubmed: 16275947
J Appl Lab Med. 2021 Sep 1;6(5):1386-1389
pubmed: 33822063
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Emerg Microbes Infect. 2020 Dec;9(1):2394-2403
pubmed: 33043818
Clin Infect Dis. 2021 Sep 15;73(6):e1337-e1344
pubmed: 33851216
J Infect Dis. 2021 Feb 3;223(2):197-205
pubmed: 33535236
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):396-401
pubmed: 33735160
J Am Geriatr Soc. 2021 May;69(5):1140-1146
pubmed: 33764497
J Am Geriatr Soc. 2021 Aug;69(8):2063-2069
pubmed: 33861873
J Med Virol. 2020 Oct;92(10):2050-2054
pubmed: 32383183
Lancet. 2021 Apr 17;397(10283):1421-1423
pubmed: 33844964
Braz J Infect Dis. 2021 Mar-Apr;25(2):101570
pubmed: 33773990
Clin Chem Lab Med. 2021 Apr 14;59(8):1444-1452
pubmed: 33855843
Public Health. 2020 Aug;185:1-2
pubmed: 32502747

Auteurs

Emily N Gallichotte (EN)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Mary Nehring (M)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Michael C Young (MC)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Sierra Pugh (S)

Department of Statistics, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Nicole R Sexton (NR)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Emily Fitzmeyer (E)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Kendra M Quicke (KM)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Megan Richardson (M)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Kristy L Pabilonia (KL)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Nicole Ehrhart (N)

Columbine Health Systems Center for Healthy Aging and Department of Clinical Sciences, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Bailey K Fosdick (BK)

Department of Statistics, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Sue VandeWoude (S)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Gregory D Ebel (GD)

Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH